SAMUEL VAZQUEZ-MILAN: Open Payments
NPI 1255783114 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 12 payments from 8 companies in 2025. Trend: 2023 $135 · 2024 $552 · 2025 $577
Food & beverage: $477Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $159 |
| Janssen Biotech, Inc. | 2 | $119 |
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $78 |
| Biofrontera Inc. | 1 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: SKYRIZI, TREMFYA, Sotyktu, SPEVIGO, AMELUZ, BLU-U, COSENTYX, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
